Genmab Ownership | Who Owns Genmab?
Genmab Ownership Summary
Genmab is owned by 99.95% institutional investors, and 0.05% retail investors. Alliancebernstein is the largest institutional shareholder, holding 23.02% of GMAB shares. AllianceBernstein US L/C Growth Eqty MF is the top mutual fund, with 0.93% of its assets in Genmab shares.
GMAB Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Genmab | 99.95% | - | 0.05% |
| Sector | Healthcare Stocks | 492.67% | 11.09% | -403.76% |
| Industry | Biotech Stocks | 295.31% | 11.22% | -206.53% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Alliancebernstein | 14.94M | 23.02% | $311.70M |
| Orbis allan gray | 7.92M | 12.43% | $163.64M |
| Blackrock | 5.08M | 7.78% | $127.67M |
| Arrowstreet capital, limited partnership | 3.45M | 5.42% | $71.37M |
| Harding loevner lp | 2.92M | 4.59% | $60.42M |
| Marshall wace, llp | 1.91M | 2.99% | $39.40M |
| Renaissance | 1.93M | 2.97% | $40.20M |
| Two sigma investments, lp | 1.71M | 2.63% | $35.61M |
| Two sigma advisers, lp | 1.65M | 2.55% | $34.51M |
| Brandywine global investment management | 1.62M | 2.50% | $33.80M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Avidity partners management lp | 650.00K | 2.68% | $13.43M |
| Aimz investment advisors | 164.51K | 1.58% | $5.05M |
| Private wealth advisors | 148.34K | 1.12% | $3.06M |
| Orbis allan gray | 7.92M | 0.80% | $163.64M |
| Harding loevner lp | 2.92M | 0.41% | $60.42M |
| Point72 europe (london) llp | 471.70K | 0.38% | $9.75M |
| Legacy wealth asset management | 46.59K | 0.35% | $1.43M |
| Tema etfs | 132.04K | 0.34% | $4.05M |
| Eagle global advisors | 244.47K | 0.29% | $7.50M |
| Gallacher capital management | 21.67K | 0.26% | $664.66K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Orbis allan gray | 7.92M | 0.80% | 2.21M |
| Arrowstreet capital, limited partnership | 3.45M | 0.05% | 2.08M |
| Brandywine global investment management | 1.62M | 0.25% | 1.62M |
| Ubs group | 1.44M | 0.01% | 1.38M |
| Two sigma advisers, lp | 1.65M | 0.08% | 1.04M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Capital investors | - | - | -2.57M |
| Wellington management group llp | - | - | -2.31M |
| Deep track capital, lp | - | - | -2.00M |
| Jpmorgan chase | 118.18K | 0.00% | -815.13K |
| Ddd partners | - | - | -601.05K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Brandywine global investment management | 1.62M | 0.25% | 1.62M | $33.80M |
| Avidity partners management lp | 650.00K | 2.68% | 650.00K | $13.43M |
| Point72 europe (london) llp | 471.70K | 0.38% | 471.70K | $9.75M |
| Federated hermes | 422.94K | 0.02% | 422.94K | $12.97M |
| Cibc world market | 279.93K | 0.02% | 279.93K | $8.59M |
Sold Out
| Holder | Change |
|---|---|
| Zurcher kantonalbank (zurich cantonalbank) | -1.00 |
| Mendota financial group | -8.00 |
| Group one trading | -8.00 |
| Baillie gifford | -12.00 |
| Clarivest asset management | -13.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 219 | -3.52% | 63,692,065 | -1.88% | 99 | 0.96% | 116 | -11.45% | 74 | 12.12% |
| Mar 31, 2025 | 226 | -2.59% | 64,889,241 | 6.75% | 101 | 1.16% | 129 | 3.20% | 67 | -10.67% |
| Dec 31, 2024 | 154 | -31.56% | 35,827,984 | -31.48% | 55 | 0.85% | 73 | -42.52% | 59 | -9.23% |
| Sep 30, 2024 | 224 | 1.36% | 52,289,656 | 7.32% | 80 | 1.43% | 126 | 32.63% | 65 | -29.35% |
| Jun 30, 2024 | 218 | -5.63% | 48,717,902 | 1.76% | 74 | 1.39% | 94 | -27.69% | 90 | 25.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| AllianceBernstein US L/C Growth Eqty MF | 5.71M | 0.93% | - |
| AB Large Cap Growth A | 4.10M | 0.67% | - |
| iShares Biotechnology ETF | 2.42M | 0.39% | - |
| Vanguard Health Care Inv | 2.29M | 0.36% | - |
| T. Rowe Price International Gr Eq SMA | 1.90M | 0.30% | 1.90M |
| First Trust NYSE Arca Biotech ETF | 1.59M | 0.26% | - |
| AB US Large Cap Growth CT B | 1.39M | 0.23% | - |
| AB American Growth AX USD | 1.19M | 0.19% | -52.71K |
| American Growth One D | 1.19M | 0.19% | -47.56K |
| Xtrackers S&P 500 Swap ETF 1C | 1.02M | 0.16% | 1.02M |
GMAB Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools